Breaking News, Promotions & Moves

Pfizer Names Andrew Baum Chief Strategy and Innovation Officer, EVP

Baum brings 30 years of experience leading high-impact research projects and teams, developing robust strategies and forging global partnerships.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pfizer Inc. has named Andrew Baum, M.D., as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla. He joins the company from Citi, where he served as Head of Global Healthcare, Managing Director Equity Research. Prior to joining Citi in 2011, Dr. Baum covered European Pharmaceuticals at Morgan Stanley for 14 years and earlier in his career was a practici...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters